Content By Patrick Stone

Patrick Stone’s picture

By: Patrick Stone

It’s clear that the Food and Drug Administration (FDA) should have more compounding pharmacy oversight, but how long will it take them to make other important decisions on public health?

The recent news is troubling.

Patrick Stone’s picture

By: Patrick Stone

Compounding pharmacies, where the creation of a particular pharmaceutical product to fit the unique needs of a patient is done, have enjoyed the protection of their state pharmacy board, or they don’t distribute outside their home state (no interstate sales).

Patrick Stone’s picture

By: Patrick Stone

During a debate with then-President Jimmy Carter, Ronald Reagan famously asked Americans if they were better off than they were four years previously. It worked for Reagan, so we’re going to try a variation of it here.

Is the Food and Drug administration (FDA) better off than it was four or five years ago?

Patrick Stone’s picture

By: Patrick Stone

Speed up approval for new health care products and minimize a major drug shortage. Sounds good so far, right? Let’s hope lawmakers get this right with a new bill designed to speed delivery and avert shortages of life-saving medicines.

Patrick Stone’s picture

By: Patrick Stone

What products will be affected by the Food and Drug Administration’s (FDA) quality by design (QbD) stipulation, as outlined in its report, “Pharmaceutical Quality for the 21st Century: A Risk-Based Approach”?

Patrick Stone’s picture

By: Patrick Stone

I don’t know about you, but I sleep easier now knowing that our Food and Drug Administration (FDA) has declared war on unpasteurized milk in the United States [Editors note: also see Fox News, NaturalNews.com]. It’s not enough that the U.S.

You can create content!

  • Classifieds
  • File Share
  • Forum Topic
  • Events
  • Links

Sign In to get started!